Laporan penilaian publik Eropa (EPAR) untuk obat-obatan manusia: Eltrombopag Accord, eltrombopag, Tanggal otorisasi: 28/03/2025, Revisi: 6, Status: Diotorisasi
Eltrombopag Accord is a medicine used for the treatment of: Eltrombopag Accord contains the active substance eltrombopag and is a ‘generic medicine’.